Fortunato Michael, Lin Fangyi, Uddin Anaz, Subah Galadu, Patel Rohan, Feldstein Eric, Lui Aiden, Dominguez Jose, Merckling Matthew, Xu Patricia, McIntyre Matthew, Gandhi Chirag, Al-Mufti Fawaz
Department of Neurology, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Brain and Spine Institute, Westchester Medical Center, New York Medical College, Valhalla, NY 10595, USA.
Brain Sci. 2023 Oct 23;13(10):1498. doi: 10.3390/brainsci13101498.
Frailty is an emerging concept in clinical practice used to predict outcomes and dictate treatment algorithms. Frail patients, especially older adults, are at higher risk for adverse outcomes. Aneurysmal subarachnoid hemorrhage (aSAH) is a neurosurgical emergency associated with high morbidity and mortality rates that have previously been shown to correlate with frailty. However, the relationship between treatment selection and post-treatment outcomes in frail aSAH patients is not established. We conducted a meta-analysis of the relevant literature in accordance with PRISMA guidelines. We searched PubMed, Embase, Web of Science, and Google Scholar using "Subarachnoid hemorrhage AND frailty" and "subarachnoid hemorrhage AND frail" as search terms. Data on cohort age, frailty measurements, clinical grading systems, and post-treatment outcomes were extracted. Of 74 studies identified, four studies were included, with a total of 64,668 patients. Percent frailty was 30.4% under a random-effects model in all aSAH patients ( < 0.001). Overall mortality rate of aSAH patients was 11.7% when using a random-effects model ( < 0.001). There was no significant difference in mortality rate between frail and non-frail aSAH patients, but this analysis only included two studies and should be interpreted cautiously. Age and clinical grading, rather than frailty, independently predicted outcomes and mortality in aSAH patients.
衰弱是临床实践中一个新兴的概念,用于预测预后并指导治疗方案。衰弱的患者,尤其是老年人,出现不良预后的风险更高。动脉瘤性蛛网膜下腔出血(aSAH)是一种神经外科急症,其发病率和死亡率很高,此前已证明与衰弱相关。然而,衰弱的aSAH患者的治疗选择与治疗后预后之间的关系尚未明确。我们根据PRISMA指南对相关文献进行了荟萃分析。我们使用“蛛网膜下腔出血 AND 衰弱”和“蛛网膜下腔出血 AND 衰弱的”作为检索词,在PubMed、Embase、Web of Science和谷歌学术上进行了检索。提取了有关队列年龄、衰弱测量、临床分级系统和治疗后预后的数据。在74项被识别的研究中,纳入了4项研究,共有64,668名患者。在所有aSAH患者中,随机效应模型下的衰弱百分比为30.4%(<0.001)。使用随机效应模型时,aSAH患者的总体死亡率为11.7%(<0.001)。衰弱和非衰弱的aSAH患者之间的死亡率没有显著差异,但该分析仅包括两项研究,应谨慎解读。年龄和临床分级而非衰弱独立预测aSAH患者的预后和死亡率。